Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease

Kurtul A., Elcik D.

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.236, ss.61-64, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 236
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.ijcard.2017.02.061
  • Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.61-64
  • Anahtar Kelimeler: Procalcitonin, Coronary atherosclerotic burden, Stable coronary artery disease, SYNTAX SCORE, MYOCARDIAL-INFARCTION, INTERVENTION, INFLAMMATION, MONOCYTES, ASSOCIATION, EXPRESSION, CYTOKINES
  • Erciyes Üniversitesi Adresli: Hayır

Özet

Objectives: Higher coronary atherosclerotic burden has been associated with increased cardiovascular events including mortality. The SYNTAX score (SXs) reflects coronary atherosclerotic burden. Given the body of evidence implicating inflammation in atherosclerotic process, we hypothesized that procalcitonin (PCT) as an inflammatory marker may be related to coronary atherosclerotic burden. Thus, we aimed to investigate the relationship between serum PCT levels and SXs in patients with stable CAD.